Matricelf Ltd (MTLF) - Cash Flow Conversion Efficiency

Latest as of June 2025: -997.589x

Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million ≈ $-22.18K USD) by net assets (ILA8.29K ≈ $22.24 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MTLF stock market capitalisation for the company's overall valuation and market capitalisation.

Matricelf Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Matricelf Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency. See MTLF debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
TMK Energy Ltd
AU:TMK
-0.030x
Garden Stage Limited Ordinary Shares
NASDAQ:GSIW
-0.034x
Shin Poong Pap
KO:002870
0.008x
Retractable Technologies Inc
NYSE MKT:RVP
-0.008x
SCI Electric Public Company Limited
BK:SCI
0.031x
Prefab Bucures
RO:PREH
0.052x
Australian Rare EARTHS Ltd
AU:AR3
-0.007x
NOMADAR Corp. Class A Common Stock
NASDAQ:NOMA
-0.042x

Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. View latest Matricelf Ltd stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA15.17 Million
≈ $40.66K
ILA-11.75K
≈ $-31.51
-0.001x -98.09%
2023-12-31 ILA26.80 Million
≈ $71.86K
ILA-10.49K
≈ $-28.12
0.000x +99.83%
2022-12-31 ILA35.79 Million
≈ $95.96K
ILA-8.30 Million
≈ $-22.25K
-0.232x +8.20%
2021-12-31 ILA26.23 Million
≈ $70.32K
ILA-6.62 Million
≈ $-17.76K
-0.253x +79.57%
2020-12-31 ILA2.80 Million
≈ $7.50K
ILA-3.46 Million
≈ $-9.27K
-1.236x -1354.61%
2019-12-31 ILA3.62 Million
≈ $9.71K
ILA-307.80K
≈ $-825.19
-0.085x --

About Matricelf Ltd

TA:MTLF Israel Biotechnology
Market Cap
$20.82 Million
ILA7.77 Billion ILA
Market Cap Rank
#25077 Global
#358 in Israel
Share Price
ILA265.60
Change (1 day)
+1.26%
52-Week Range
ILA227.10 - ILA785.80
All Time High
ILA1480.00
About

Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more